StockData
PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30

PharmaCyte Biotech, Inc.

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$0.34+0.00 (+0.53%)

Close on Oct 19, 2026

Market cap
$3.67M
P/E (TTM)
–
Dividend yield
–

PharmaCyte Biotech statistics

Financials through Jul 31, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison

Valuation

MeasurePharmaCyte BiotechIndustry median
Market Cap$3.67M$197.05M
Enterprise Value-$14.17M$106.56M
PB Ratio0.132.14
P/TBV Ratio0.132.46

Income (trailing twelve months)

MeasurePharmaCyte BiotechIndustry median
Revenue$0$57.94M
Operating Income-$6.85M-$21.44M
Net Income-$19.42M-$22.46M
EBITDA-$6.85M-$16.91M
EPS (Diluted)-$2.77-$0.83

Returns

MeasurePharmaCyte BiotechIndustry median
Return on Equity (ROE)-70.6%-53.1%
Return on Assets (ROA)-52.9%-41.0%
Return on Invested Capital (ROIC)-56.0%-32.0%
Return on Capital Employed (ROCE)-19.1%-37.8%

Growth

MeasurePharmaCyte BiotechIndustry median
Net Income Growth (YoY)-163.4%-37.7%

Balance sheet

MeasurePharmaCyte BiotechIndustry median
Cash & Short-Term Investments$17.84M$62.42M
Net Cash (Debt)$17.84M$15.68M
Net Cash Per Share$1.66$0.65
Equity (Book Value)$27.51M$48.79M
Book Value Per Share$2.56$1.36
Tangible Book Value$27.51M$23.06M
Working Capital$30.21M$75.77M

Financial position

MeasurePharmaCyte BiotechIndustry median
Current Ratio40.303.30
Quick Ratio23.212.39

Cash flow (trailing twelve months)

MeasurePharmaCyte BiotechIndustry median
Operating Cash Flow-$5.15M-$12.35M

Efficiency

MeasurePharmaCyte BiotechIndustry median
Asset Turnover0.000.38
Revenue Per Employee$0$398.96K
Profits Per Employee-$9.71M-$732.08K
Employee Count273

Dividends and yields

MeasurePharmaCyte BiotechIndustry median
Earnings Yield-529.1%-21.2%
Buyback Yield10.9%-0.58%
Shareholder Yield10.9%0.00%

Shares

MeasurePharmaCyte BiotechIndustry median
Shares Outstanding10,735,60059,128,900
Shares Change (YoY)14.3%11.1%
Shares Change (QoQ)0.00%0.54%
Float9,975,06048,744,500
Shares Held by Insiders7.08%11.8%
Shares Held by Institutions7.10%59.4%

Scores

MeasurePharmaCyte BiotechIndustry median
Altman Z-Score-3.480.10
Piotroski F-Score34

Calculated by StockData from PharmaCyte Biotech's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.